Fall 2002 - American Academy of Dermatology

AUGUST/SEPTEMBER 2002
DERMATOLOGY
Resident
Official publication of the
Resident & Fellows Committee,
American Academy
of Dermatology Association
Supported by an educational grant
from Berlex Laboratories, Inc.
AMA supports ACGME report calling for shorter resident work hours
In June, at the American Medical
Association’s Annual Meeting in Chicago,
the Resident Fellows Section debated the
Accreditation Council for Graduate Medical
Education (ACGME) report on resident
duty hours. The ACGME, which accredits
teaching hospitals in the United States,
announced that beginning in July, 2003, it
will limit the work week for residents to
80 hours and will require that residents
have at least 10 hours of rest between shifts
and do not work more than 24 hours
at a time. Hospitals could lose their
accreditation if they do not comply with
the regulations.
While residents attending the meeting
were generally supportive of the proposed
new limits, some are concerned that
loopholes in the guidelines could result in
little real change. The guidelines do not set a
flat 80-hour work week; rather they allow
time to be averaged over a period of two
weeks or one month. The days off provision,
stating that one day off is required every seven
days, could also be averaged over the period.
The AMA endorsed a version of the ACGME
report in June during their annual meeting
in Chicago. More information about the
meeting is available on the AMA Web site at
www.ama-assn.org/ama/pub/category/7096.html. RR
MERCEDEA BAGHAI, M.D., GIVES A RESIDENT’S POINT OF
VIEW ABOUT WORK HOUR ISSUES DURING REFERENCE
COMMITTEE A AT THE AMA ANNUAL MEETING.
Membership — don’t leave your residency without it
G r a d u a t e
Membership in the
American Academy
of Dermatology
ceases upon
completion of your
residency. To meet
your future and
continuing needs in education, you should
consider full membership in the AAD. The
Academy was founded to promote the
highest possible standards in clinical
practice, education and research in
dermatologic medicine and surgery and
related disciplines. To meet this obligation,
the Academy has developed a series of
educational programs that include the
Annual National Meeting, regional
postgraduate courses, self-assessment
examinations, home study programs, and a
voluntary Continuing Medical Education
Transcript/Award Program. The Academy is
also working closely with the American
Board of Dermatology and the Association
of Professors of Dermatology in developing
standards to ensure continuing competency.
During your residency training, a
subscription to the Journal of the American
Academy of Dermatology, (JAAD) was
provided to you on a complimentary basis.
If you apply and are accepted for
postgraduate AAD membership, a
subscription for JAAD will automatically be
sent to you as part of your membership dues
beginning with the January 2003 issue.
Membership applicants will receive a
complimentary six month JAAD subscription
(July-December, 2002). Non-applicants
must subscribe to JAAD on their own.
In addition to educational activities, the
Academy is active in the field of socioeconomics and maintains close liaisons
with other specialty branches of medicine
and medicine in general.
The Academy is composed of more than
14,000 members with almost all practicing
dermatologists listed in our membership
files. The Membership Committee and the
Board of Directors will consider all
individuals who apply for membership prior
to September 1 for active status in 2003. As
an applicant you will be invited to attend
the 2003 Annual Meeting in San Francisco,
March 21-26, at the special member rate.
Membership in the Academy is $550.00
U.S. dollars. This amount represents your
reduced first year‘s (2003) dues plus a
$100.00 non-refundable application
initiation fee. Please also include two
photographs approximately 2½ x 2½ for use
in our office. Upon receipt of the completed
form, your two endorser letters, your check
and photographs, we will begin processing
your request for membership. In order for
your application to be considered for 2003
membership, your application must be
returned by September 1.
To request an application please contact
Debra Kroncke, membership manager,
American Academy of Dermatology, P.O. Box
4014, Schaumburg, IL 60168-4014; phone,
(847) 240-1289; e-mail [email protected]. RR
IN SID E T H IS I S S U E ...
• MESSAGE FROM THE CHAIR ....................................... 4
• NEW SLOTS OPEN FOR RFC ........................................ 4
• ARE YOU BEING HONEST? .......................................... 5
• GENES TO KNOW .................................................... 6-7
DERMATOLOGY RESIDENT ROUNDUP • AUGUST/SEPTEMBER 2002
Message from the chair
By Joel Gelfand, M.D.
Hello colleagues! I
want to take this
opportunity to let you
know about the
activities of the
Resident and Fellows
Committee (RFC)
and to encourage you
to get involved with
the American
Academy of Dermatology. The RFC is
dedicated to representing issues important to
dermatology residents and fellows of the
Academy. Therefore, we want to hear from you
about dermatology issues that concern you.
The RFC has played an important role in
such issues as making the match concurrent
with matches in other medical specialties.
More recently, the RFC has played an
important role in moving the board
examination date to August, a position
supported by the majority of dermatology
residents (the board exam date change will
be affecting those completing their
residencies in 2003). The RFC is composed
of 12 residents who represent their respective
geographic areas. Each resident is on the
committee for a two-year term.
The committee has four officers, the
c h a i r, v i c e - c h a i r, s e c r e t a r y, a n d a
representative to the American Medical
Association (AMA). The chair of the RFC
also represents resident issues by being an
observer to the Academy’s Board of
Directors. The vice-chair organizes the
annual resident’s colloquia at the AAD
annual meeting at which dermatologists
from a variety of disciplines within our
specialty speak to residents about career
opportunities. The vice-chair also reports
on the RFC’s activities directly to the
Advisory Board of the AAD. The secretary
is involved in preparing the AAD’s Resident
Roundup, your place to learn about
important AAD issues that affect you. The
secretary also updates a directory on
dermatology fellowships, which is
available to you through the AAD and is
on the resident section of the AAD Web
site, www.aad.org. The RFC representative
to the AMA attends AMA meetings and
advocates for our residents within the
AMA. The RFC w o r k e d w i t h t r a i n e e s
f r o m o t h e r specialties and the AMA to
support bill S. 1762. This bill, signed into
law on Feb. 8, 2002, locks in the current
federal student loan rate (the lowest in the
programs history) until 2006! For more
information, see the March/April 2002
issue of Dermatology Resident Roundup.
The RFC is a great way to get involved
with the Academy and an important way
by which residents are represented in your
specialty. The AAD is responsive to resident
concerns and wants our input. If you are
interested in serving on the RFC or want to
discuss any issue, I want to hear from you!
Feel free to contact me by email,
[email protected]. RR
New slots open for RFC in ’03
As member terms expire on the American
A c a d e my o f D e r m a t o l o g y a n d A A D
Association Resident and Fellows
Committee (RFC), new slots will open up
for those who are interested in becoming
RFC Regional Representatives. The RFC is
comprised of 12 members representing the
same number of regions in the United
States and Canada. Regional representatives
alternate their terms of office so that the
work of the RFC is not interrupted.
The RFC supports the interests of and
addresses issues of concern to residents,
fellows, and newly-practicing physicians. It
promotes effective communication and
action toward these ends between
individuals, training programs, graduate
medical education societies, and the AAD
and AADA.
The Committee meets once each year
during the Academy’s Annual Meeting.
Regional Representative vacancies will be
r e c r u i t e d i n t h e f al l , e f f e ct i ve at t h e
Academy’s 2003 Annual Meeting. The
following regions will be recruiting new
representatives:
• Region 2: New York
• Region 3: Connecticut, Rhode Island,
New Jersey, Pennsylvania
• Region 4: Maryland, West Virginia,
Delaware, Virginia, North Carolina,
District of Columbia
• Region 5: South Carolina, Georgia,
Florida, Puerto Rico
• Region 6: Michigan, Wisconsin
• Region 10: Texas
Residents in these six regions should
contact their program director at the
beginning of the school year for additional
information. An RFC representative has a
two-year term, so only first- and secondyear students are recruited. For more
information, contact RFC Staff Liaison
Sandra Peters at (847) 240-1819 or e-mail
[email protected]. RR
NEWS FROM THE AMA
House bill redistributes unused residency slots for DGME payments
Under Medicare legislation (H.R. 4954) passed by the U.S. House of Representatives in June, the portion of a hospital’s resident
limit (as mandated by the Balanced Budget Act of 1997) that is being “unused” would be redistributed to teaching hospitals
seeking to increase their resident limits. The slots that would be redistributed would be eligible for direct graduate medical
education (DGME) payments, but not indirect medical education (IME) payments. Read the complete story on line at:
www.aamc.org/advocacy/library/washhigh/2002/071202/_3.htm RR
4
DERMATOLOGY RESIDENT ROUNDUP • AUGUST/SEPTEMBER 2002
Seeking new authors for self-assessment examination
The Self-Assessment/Recertification Task
Force of the American Academy of
Dermatology is seeking new authors to
develop self-assessment examinations. The
self-assessment examinations are
published bi-monthly in the Journal of the
American Academy of Dermatology and
consist of a brief case history and a series
of multiple choice questions each with five
possible responses.
A description follows the questions
highlighting the correct response and the
correct answer is listed at the conclusion of
the description. A bibliography is listed to
provide additional references. At the
conclusion of the self-assessment learning
activity, physician participants should be
able to assess their own diagnosis and
patient management skills with respect to
those of their colleagues in the field, use
the results of the self-assessment to help
determine personal learning needs that
can be addressed
through subsequent
C M E i n vo l v e m e n t ,
and enhance their
ability to comply
with the requirements
for certification in
the specialty of
dermatology.
The Self-Assessment/
Recertification Task
Force encourages
residents and young
physicians to
consider developing
self-assessment
examinations as a way to contribute to the
field of dermatology and gain recognition
a m o n g t h e i r p e e r s. S e l f - a s s e s s m e n t
examinations in JAAD are also cited in Index
Medicus. Examples of
previously published
self-assessment
examinations may be
requested from the
AAD Department of
Education. Interested
authors should contact
Dr. Mary Spellman,
c h a i r o f t h e
Self-Assessment/
Recertification Task
Force by e-mail at
[email protected] or
contact Susan Carlson,
Senior Manager, AAD
Department of Education, phone
(847) 240-1696, e-mail [email protected]. RR
group concluded that blatant deception by
dermatology applicants is minimal.
As an interesting aside, they found
that 28 applicants claimed 45
manuscripts were “submitted for
publication,” but only eight applicants
(28%) published a total of 12 articles
(27%). Further, 28 applicants claimed 45
manuscripts were “in preparation/in
progress,” but only two applicants (7%)
published a total of two articles (4%).
These two categories do not easily lend
themselves to misrepresentation, but do
demonstrate the lack of substantive
information about the applicant.
Faculty at New Jersey Medical School
concurred with the Vanderbilt faculty that
the overwhelming majority of
dermatology applicants record their
publications in good faith. They add that
using MEDLINE to verify citations may
miss citations in book chapters or in
r e a s o n a b l y g o o d m e d i c a l j o u r n a l s,
e s p e c i a l l y i n t e r n a t i o n a l l y. T h e y
recommend that to verify the validity of
publications, mentors should provide
students with copies of submission letters
and other correspondence and document
their work in their own letters
of recommendation.
On the forum, a poll was started to
determine the honesty of the voters. When
posed about the honesty of prior votes on
other polls to compare credentials, only 2
out of 50 responders said that they had
falsified some responses. I conclude as well
that, in addition to their abundance of
intellectual capacity and strong work ethic,
the dermatology applicant pool is also
blessed with honesty. RR
Are you being honest?
By Jashin J. Wu, B.A.
Some students have voiced concerns on the
Dermatology Residency Forum that some
people may be voting on the polls in a way
to shift a poll in a particular manner.
Multiple voting cannot be prevented, and
some fear that others may be voting several
times to achieve an ulterior purpose by
scaring away some applicants from even
applying. Further, some have realized that
a breech in integrity may be easily
accomplished when submitting the
curriculum vitae (CV), as busy reviewers
may not bother to double-check the validity
of the applicants’ claims.
Falsification of achievements when
applying for a fellowship has been reported,
but misrepresentation by dermatology
applicants was found to be less widely
reported than in other fields or
circumstances. Faculty at Vanderbilt
University evaluated the accurateness of the
bibliography of 138 applicants for the
October 1994 residency match. Cited
articles were placed in the categories of
“published,” “in print/in press,” “submitted
for publication,” and “in preparation/in
progress.” Of the 52 applicants who were
claiming published articles in the MEDLINE
database, 49 were accurate and 117 citations
(97%) were accounted for. The Vanderbilt
5
Jashin (Jay) Wu,
B.A., is a first-year
resident in the
Baylor College
of Medicine
preliminary
internal medicine
program. The
Dermatology
Residency forum
is located at http://pub50.ezboard.com/
bdermatology. Every Sunday from 6 to 9
p.m. Eastern time, there are online chats
between dermatology applicants,
matchers, and residents. If you have any
questions about participating in the
forum and chats, please contact Jay at
[email protected]
DERMATOLOGY RESIDENT ROUNDUP • AUGUST/SEPTEMBER 2002
Dermatology Boards Fodder: Genes to Know
By Benjamin A. Solky, M.D., and Brian Selkin, M.D.
The purpose of this column is to alert dermatology residents to areas that are considered “high yield” for the mock and real boards in dermatology.
This installment identifies commonly asked and highly askable factoids relating to genetic inheritance of diseases.
DISEASE
GENE
GENE FUNCTION
Atrichia with Papules ‘Alopecia Universalis’
PATTERN
AR
(HR) HAIRLESS GENE
Zinc Finger
Oculocutaneous Albinism I
AR
TYROSINASE
Melanin Pathway
Oculocutaneous Albinism II
AR
P GENE
Unknown
Oculocutaneous Albinism III (Rufuos)
AR
(TRP1) TYROSINE RELATED PROTEIN
Stabilizes Tyrosinase
Alkaptonuria
AR
HOMOGENTISIC ACID OXIDASE
Phenylalanine & Tyrosine Breakdown Pathway
Hereditary Angioedema (Quinke’s)
AD
(C1INH) C1 ESTERASE INHIBITOR
Inhibits first component of complement
Ataxia-Telangiectasia (Louis Bar)
AR
ATM
PI3-kinase like domain
Baere-Stevenson Syndrome
(FGFr2) FGF RECEPTOR 2
Bannayan-Riley-Ruvalcaba
AD
PTEN
Tumor Suppressor
Bart’s Syndrome
AD
(COL7A1) TYPE VII COLLAGEN
Anchoring Fibril
Gorlin Syndrom
AR
(PTCH) PATCHED
(Nevoid Basal Cell Carcinoma Syndrome)
Inhibits “SMOOTHENED” signalling, this
inhibition blocked by “HEDGEHOG”
Bloom’s Syndrome
AR
(BLM) (RECQL3)
DNA helicase
Bruton’s Agammaglobulinemia
XLR
(BTK GENE)
Tyrosine Kinase
Bullous Ichthyosiform Er ythroderma
AD
KERATINS 1 & 10
Intermediate filament
Carney Complex (LAMB, NAME)
AD
(PRKAR1A)
Regulatory Subunit of Protein Kinase A
Chediak-Higashi Syndrome
AR
LYST
Lysosomal Transport
CHILD Syndrome
XLD
(EBP GENE) EMOPAMIL BINDING PROTEIN
Sterol Isomerase
XLR
CYTOCHROME B
NADPH-OXIDASE complex component (Respiratory
ARGINOSUCCINATE SYTHETASE
Enzyme in urea cycle
(Epidermolytic Hyperkeratosis)
Chronic Granulomatous Disease of Childhood
(mostly)
Citrullinemia
AD
Burst) needed to kill catalase positive bacteria
Cockayne’s Syndrome
AR
(CKN1) (ERCC6) XPB DNA HELICASE
DNA Helicase
Conradi-Hünermann Syndrome
XLD
(EBP)
Sterol Isomerase
AR
(PEX7)
Peroxisomal gene
Cowden’s Syndrome (Multiple HamartomaSyndrome)
AD
(PTEN)
Tumor Suppressor
Darrier-White Disease (Keratosis Follicularis)
AD
(SERCA2) CALCIUM ATPase2A2
Calcium Dependent ATPase
Dyskeratosis Congenita
XLR
DYSKERIN
Ribosome Assembly Chaperone
AD
(TERC) TELOMERASE, RNA COMPONENT
Telomerase RNA Component
Dominant Dystrophic Epidermolysis Bullosa
AD
(Col7A1) Type VII COLLAGEN
Anchoring Fibril
(BPAg2) COLLAGEN XVII
Structural Protein
GABEB
(LAMB3) LAMININ
Junctional EB with Pyloric Atresia
AR
INTEGRIN α6,b4
Structural
Junctional EB (EB Letalis, HERLITZ)
AR
LAMININ 5
Structural
EBS
AD
KERATINS 5 & 14
Intermediate filament
EBS with Myotonic Dystrophy
AR
PLECTIN
Structural
Hidrotic Ectodermal Dysplasia (Clouston’s)
AD
CONNEXIN 30
Gap Junction Protein
Structural
Ectodermal Dysplasia with Skin Fragility
AD
PLAKOPHILIN 1
Ectod. Dyspl., Hypohidrotic
XLR
ECTODYSPLASIN
(Christ-Seimens-Touraine Syndrome)
Erythrokeratoderma Variabilis (EKV)
AD
CONNEXIN 31
Gap Junction Protein
Fabry’s Disease (Angiokeratoma Corporis Diffusum)
XLR
ALPHA-GALACTOSIDASE A
Hydrolyzes Glycolipids and Glycoproteins
Familial Mediterranean Fever
AR
(MEFV) MARENSTRIN
PMN inhibitor
Farber’s Disease (Lipogranulomatosis)
AR
ACID CERAMIDASE
Deficiency Leads to CERAMIDE ACCUMULATION
Gardner’s Syndrome
AD
(APC)
Cleaves β-Catenin
Gaucher’s Disease
AR
β-GLUCOCEREBROSIDASE
Griscelli Syndrome
AR
(MTO5a) MYOSIN-Va
Melanosome Transpor t To Keratinocytes
Hailey-Hailey Disease
AD
(ATPase2C1)
Calcium Dependent ATPase
Herditar y Hemorrhagic Telangiectasia
AD
ENDOGLIN
TGF-β Binding Protein
(Osler-Weber-Rendu)
ALK-1 GENE ACTIVIN RECEPTOR BINDING KINASE TGF-β Receptor
6
DERMATOLOGY RESIDENT ROUNDUP • AUGUST/SEPTEMBER 2002
DISEASE
GENE
GENE FUNCTION
Homocystinuria
PATTERN
AR
CYSTATHIONE SYNTHETASE
Condensation of Homocysteine & Serine
Hunter’s Syndrome
XLR
IDURONATE SULFATASE
Hurler’s Syndrome
AR
ALPHA-L-URONIDASE
Ichthyosis, Lamellar
AR
Ichthyosis, X-Linked
XLR
ARYL SULFATASE C
Incontinentia Pigmenti
XLD
(NEMO) NF-κB essential modulator
Transcription Factor
Lesch-Nyhan Syndrome
XLR
(HGPRT)
Purine Salvage Pathway Enzyme
Tumor Suppressor
TRANSGLUTAMINASE-1
Steroid Sulfatase
Lhermite-Duclos Syndrome
AR
(PTEN)
McCune-Albright Syndrome
None
(Gs-α)
Stimulates G protein increasing cAMP
MEN I
AD
(MEN1) MENIN GENE
Binds nuclear junD
MEN IIa and IIb
AD
(RET) RECEPTOR TYROSINE KINASE
Proto-oncogene
Menke’s Kinky Hair Syndrome
XLR
MNK
Copper Transporting ATPase
Milroy’s Disease (Nonne-Milroy-Meige Syndrome)
AD
(FLT-4) a.k.a (VEGFr-3)
Growth factor receptor
Monilethrix
AD
KRT hHb6 & hHb1 Type II
Intermediate filament
Muir-Torre Syndrome
AD
(hMSH2)
Nail-Patella Syndrome
AD
LMX1B GENE
Homeobox domain transcripton factor
Naxos Disease
AD
JUNCTIONAL PLAKOGLOBIN
Structural Protein
KERATIN 9
Intermediate Filament
Neimann-Pick Disease
AR
SPHYNGOMYELINASE
Netherton’s Syndrome
AR
SPINK5 Gene
Serine protease inhibitor
Neurofibromatosis I
AD
NF-1 (Neurofibromin)
Increases GTPase activity of ras
Neurofibromatosis II
AD
NF-2 (Schwannomin or Merlin)
HUMAN HAIR KERATINS 6 & 1
Pachyonychia Congenita
AD/AR
K6, K16, or K17
Mismatch repair gene
Intermediate filament
Papillon-Lefevre Syndrome
AR
CATHEPSIN C
Lysosomal protease
Peutz-Jeghers Syndrome
AD
STK11
Tumor suppressor
Phenylketonuria
AR
PHENYLALANINE HYDROXYLASE
PIBIDS
AR
(XPD) (TFIIH) XERODERMA PIGMENTOSA D
DNA helicase
Piebaldism
AD
(C-kit)
Proto-oncogene (tyrosine kinase)
Porphyria Cutanea Tarda
AD
UROPORPHYRINOGEN DECARBOXYLASE
Porphyria, Acute Intermittent
AD
PORPHOBILINOGEN DEAMINASE
Porphyria, Congenital Erythropoietic (GUNTHER’S)
AR
UROPORHYRINOGEN III COSYNTHASE
Porphyria, Heriditar y Coproporphyria
AD
COPROPORHYRINOGEN OXIDASE
Mitochondrial Gene
FERROCHELATASE
Mitochondrial Gene
Mitochondrial Gene
Porphyria, Erythropoietic Protoporhyria (EPP)
AD/AR
Porphyria, Variegate
AD
PROTOPORPHYRINOGEN OXIDASE
Refsum Syndrome
AR
PHYTANOYL Co-A HYDROXYLASE
Richner-Hanhart Syndrome
AR
TYROSINE AMINOTRANSFERASE
Rothman-Thompson (Poikiloderma Congenital)
AR
(RECQL4) DNA HELICASE
DNA helicase
Rubenstein-Taybi Syndrome
AD
(CBP) CREB-BINDING PROTEIN
Involved in cAMP regulated gene expression
SCID Severe Combined Immunodeficiency Disease
AR
(ADA) ADENOSINE DEAMINASE
XLR
Il-2 RECEPTOR
Bullous Ichthyosis of Siemens
AD
KERATIN 2e
Sjögren-Larsson Syndrome
AR
FATTY ALDEHYDE DEHYDROGENASE
Intermediate filament
Striate PPK 1
AD
DESMOGLEIN-1
Structural Protein
Striate PPK 2
AD
DESMOPLAKIN
Structural Protein
Takahara’s Disease
AR
CATALASE
Bacterial Defense
Tangier Disease
AR
(CERP)
Cholesterol efflux regulatory protein
Tuberous Sclerosis
AD
(TSC1) on Chrom. #9 HAMARTIN GENE
Vohwinkel’s
AD
LORICRIN GENE
Structural
Vohwinkel’s with deafness
AD
CONNEXIN 26
Gap Junction Protein
Vorner’s Syndrome
AD
KERATIN 9
Intermediate filament
Waardenburg’s Syndrome
AD
(PAX3)
Transcription factor
(TSC2) on Chrom. #16 TUBERIN GENE
GTPase activating protein domain
(MITF) (EDN3/SOX10)-with Hirschprung’s
Transcription factor Endothelin
AR
(WRN) (ERCC) (XPB, D, and G)
DNA helicase
White Sponge Nevus
AD
KERATIN 4 & 13
Intermediate filament
Wiskott-Aldrich Syndrome
XLR
(WASP) (sialoglycoprotein)
Binds GTPase & Actin
Werner’s Syndrome
7
RR
DERMATOLOGY RESIDENT ROUNDUP • AUGUST/SEPTEMBER 2002
Practice management products available
The American Academy has developed a
new Practice Management Essentials Series,
a set of publications written to help
dermatologists comply with the variety of
federal laws applicable to their offices.
The first offering from the series is
HIPAA Privacy Standards: A Practical Guide
for Dermatology Practices, which provides
dermatologists with information they need
to comply with the privacy regulations
mandated under the Health Insurance
Portability and Accountability Act of 1996
(HIPAA). By April 14, 2003, all physicians
must abide by these regulations. Those who
purchase the privacy manual will
automatically receive HIPAA Security
Standards: A Practical Guide for Dermatology
Practices later this year. This manual will
outline how health information should be
electronically collected, used and
transmitted to ensure security as mandated
under the HIPAA Security Standards.
The second title currently available in the
Practice Management Essentials Series is
OIG Compliance Manual: A Guide for
Dermatology Practices. The OIG manual is
designed to help d e r m a t o l o g i s t s
p r e ve n t s u b m i t t i n g erroneous claims,
detect fraud, and remain compliant with
Centers for Medicare and Medicaid claims
filing requirements.
Future titles in the Practice
Management Essentials Series include:
• OSHA
• Bloodborne Pathogens
• Starting a Dermatology Practice
• Closing a Dermatology Practice
• Valuing a Practice
For additional information on the
Practice Management Essentials Series, or to
place an order, contact the AAD Marketing
Department at (847) 240-1280. RR
ASDP HOSTS “DUEL
IN DERMATOPATHOLOGY”
The American Society of
Dermatopathology (ASDP) is sponsoring
their third annual “Duel in
Dermatopathology” competition for
dermatology and pathology residents on
Thursday, October 10, 2002, the first
evening of the ASDP 39th Annual
Meeting being held in Phoenix, Ariz.
Come and see your peers compete
for first, second and third place for the
best clinical pathological case study For
more information on this and other
ASDP activities, contact the American
Society of Dermatopathology by phone
(847) 330-9830; fax (847) 330-1135 or
e-mail [email protected]. You can also visit
the ASDP Web site, www.asdp.org. RR
DERMATOLOGY
Academy seeks Young Investigator nominations
The American Academy of Dermatology
(AAD) will mail out nomination forms for
the 2002 Awards for Young Investigators to
residency program directors in September.
The awards recognize dermatology
residents and medical students in the
United States and Canada and the
institutions who support their outstanding
research contributing to the improvement
of diagnosis and therapeutics in the science
and practice of dermatology.
Each year, two recipients are chosen from
among the nominees sent in by dermatology
program heads and faculty advisors. Winners
receive an engraved plaque and a $5,000 prize
to be shared with the nominating institution.
They will be selected at the end of the year
and the awards will be presented at the
Academy’s 2003 Annual Meeting in San
Francisco next March.
For additional information on the
Awards, including judging criteria and
nomination requirements, visit the AAD Web
site at www.aad.org/awards_young.html. RR
AAD resident, fellows mentor program available
The American Academy of Dermatology’s
Resident and Fellows Committee (RFC) has
formed a mentorship program that is
intended to serve as a resource for residents,
young physicians, and all AAD members
who have career or clinical questions
in dermatology.
The Mentorship Program has been
designed informally, and specific details,
including the scope of the mentorship, are
to be worked out on an individual basis.
This program is aimed at all residents,
fellows and young physicians.
Mentors for 2002 include:
• Michael J. Bernhardt, M.D., Jacksonville, FL*
• Richard Clark, M.D., Stony Brook, NY
• Fran E. Cook-Bolden, M.D., New York, NY
•
•
•
•
•
•
•
•
*
Ray Cornelison, M.D., Oklahoma City, OK*
Philip Fleckman, M.D., Seattle, WA*
Carlos Guillen, M.D., Valencia, SPAIN
Sandy Johnson, M.D., Little Rock, AK
Laertes Manuelidis, M.D., Charleston, SC*
Linda Spencer, M.D., Crawfordsville, IN
Virginia P. Sybert, M.D., Seattle, WA*
LaKimerly Woods-Coates, M.D., Freeport, IL*
new mentors added since last issue
Members who would like to participate
as a mentor may fill out the questionnaire
online at the AAD’s Web site, www.aad.org.
Mentors will be posted on the resident
section of the AAD Web site. For more
information about the program, contact RFC
Staff Liaison Sandra Peters by phone at (847)
240-1819, or e-mail [email protected]. RR
8
Resident
AUGUST/SEPTEMBER 2002
VOL. 6, NO. 2
RESIDENT & FELLOWS COMMITTEE
CHAIR: JOEL M. GELFAND, M.D., PHILADELPHIA, PA
VICE CHAIR: J. MATTHEW KNIGHT, M.D., KANSAS CITY, KS
SECRETARY: BENJAMIN SOLKY, M.D., BOSTON, MA
KENT S. AFTERGUT, M.D., DALLAS, TX
PAUL BOWMAN, M.D., AUGUSTA, GA
EDWARD COWEN, M.D., ROCHESTER, NY
BRAD JOHNSON, M.D., LITTLE ROCK, AR
AMY Y. JORDAN, M.D., WINSTON-SALEM, NC
ALICE LEE, M.D., CHICAGO, IL
CYNTHIA MATES, M.D., DETROIT, MI
ISAAC M. NEUHAUS, M.D., SAN FRANCISCO, CA
SAMIR PATEL, M.D., CINCINNATI, OH
EDGAR B. SMITH, M.D., CONSULTANT, ALBUQUERQUE, NM
SANDRA PETERS, AAD STAFF LIAISON, SCHAUMBURG, IL
Director, Publishing & Graphic Arts: Anne Allodi
Managing Editor: Lara Lowery
Editor: Dean Monti
Production: Lori Martin
© 2002
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
P.O. BOX 4014
SCHAUMBURG, IL 60168-4014
MISSION STATEMENT:
Dermatology Resident Roundup is published by
the American Academy of Dermatology
Association to provide a forum for
information concerning resident dermatology
physicians, and providing news, views and
actions of the Academy, the Resident & Fellows
Committee, and the American Board of
Dermatology. It is supported by an educational
grant from Berlex Laboratories, Inc.